A highly sensitive UHPLC-MS/MS method for urine biological monitoring of occupational exposure to anthracycline antineoplastic drugs and routine application
- 1 November 2020
- journal article
- research article
- Published by Elsevier in Journal of Chromatography B
- Vol. 1156, 122305
Abstract
No abstract availableKeywords
Funding Information
- Direction Générale de l’offre de Soins
This publication has 22 references indexed in Scilit:
- Surface wipe sampling for antineoplastic (chemotherapy) and other hazardous drug residue in healthcare settings: Methodology and recommendationsJournal of Occupational and Environmental Hygiene, 2016
- Sources of Variability in Biomarker ConcentrationsJournal of Toxicology and Environmental Health, Part B, 2014
- Quantitative liquid chromatographic analysis of anthracyclines in biological fluidsJournal of Chromatography B, 2011
- Simultaneous determination of cyclophosphamide, ifosfamide, doxorubicin, epirubicin and daunorubicin in human urine using high‐performance liquid chromatography/electrospray ionization tandem mass spectrometry: bioanalytical method validationRapid Communications in Mass Spectrometry, 2008
- Trace determination of anthracyclines in urine: a new high‐performance liquid chromatography/tandem mass spectrometry method for assessing exposure of hospital personnelRapid Communications in Mass Spectrometry, 2004
- Drugs Hazardous to Healthcare WorkersDrug Safety, 1999
- Anthracycline Antibiotics in Cancer TherapyDrugs, 1994
- Comparative pharmacokinetic study of idarubicin and daunorubicin in leukemia patientsHematological Oncology, 1992
- Epirubicin and doxorubicin comparative metabolism and pharmacokineticsCancer Chemotherapy and Pharmacology, 1988
- OCCUPATIONAL EXPOSURE TO CYCLOPHOSPHAMIDEThe Lancet, 1984